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CLINICAL ARTICLE
Gynecology
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Abstract
Objective: To assess correlates of long-acting reversible contraceptive (LARC) use, and
explore patterns of LARC use among female sex workers (FSWs) in Kenya.
Methods: Baseline cross-sectional data were collected between September 2016 and
May 2017 in a cluster-randomized controlled trial in Mombasa. Eligibility criteria included
current sex work, age 16–34 years, not pregnant, and not planning pregnancy. Peer
educators recruited FSWs from randomly selected sex-work venues. Multiple logistic
regression identified correlates of LARC use. Prevalence estimates were weighted to
adjust for variation in FSW numbers recruited across venues.
Results: Among 879 participants, the prevalence of contraceptive use was 22.6% for
implants and 1.6% for intra-uterine devices (IUDs). LARC use was independently associated with previous pregnancy (adjusted odds ratio for one pregnancy, 11.4; 95%
confidence interval, 4.25–30.8), positive attitude to and better knowledge of fam-

8

ily planning, younger age, and lower education. High rates of adverse effects were

9

reported for all methods.
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Conclusion: The findings suggest that implant use has increased among FSWs in Kenya.
Unintended pregnancy risks remain high and IUD use is negligible. Although LARC rates
are encouraging, further intervention is required to improve both uptake (particularly of
IUDs) and greater access to family planning services.
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Cluster-randomized design; Complex sampling; Contraceptive implant; Intra-uterine device;
Kenya; Long-acting reversible contraception; Sex work

violence or financial incentives not to use condoms.2 Therefore,

1 | INTRODUCTION

use of condoms alongside a highly effective method is critical for

Female sex workers (FSWs) in many countries have high rates of

pregnancy prevention.

unintended pregnancy,1 and experience many barriers to using

Long-acting reversible contraceptives (LARCs) including intra-

highly effective contraception. They also have difficulties negotiat-

uterine devices (IUDs) and subdermal implants, are not user-or coital-

ing condom use with clients and non-paying partners, often facing

dependent, and accord women greater control in the face of resistant
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male partners.1 LARCs are considered safe for nulliparous women and

contraception methods were defined as implant, IUD, injection, oral

women with multiple sexual partners, provided that those with a very

contraceptive pill, and permanent contraception methods (those with

high risk of sexually transmitted infections (STIs) receive STI screening

at least 90% typical use efficacy17). Full details of the study mea-

or treatment at the time of IUD insertion.

3–5

sures and variable categories are provided in Supplementary File S1.

The use of LARCs among FSWs is low in many countries,6 partic-

Knowledge about family planning was classified as high if participants

ularly in sub-Saharan Africa, where prevalence is reported as less than

answered at least five of six true-or-false statements correctly. They

5% in most studies.1,7 Use of IUDs among FSWs varies considerably

were considered to have a positive attitude to family planning if they

between regions, with higher levels in parts of Latin America and Asia.8,9

agreed with at least three of four attitude statements. Self-efficacy

Access to family planning services has increased in parts of Africa

and stigma were both measured on a 10-item scale,18,19 each rated

in recent decades.10 In Kenya, LARCs are offered at low or no cost in

between one and four, with four representing greater self-efficacy or

many public health facilities, and are used by approximately 22% of

stigma. Two additional items measured contraception-specific self-

married women.11 Uptake by FSWs, however, is unknown. Peer-based

efficacy, defined as high if participants agreed with both statements.

HIV-prevention programs for FSWs are common in HIV-endemic

All analyses were undertaken in Stata version 13 (StataCorp,

countries, but they seldom offer family planning or other sexual or

College Station, TX, USA). Correlates of LARC use were identified by

reproductive health services.12,13 Misconceptions and limited knowl-

using multiple logistic regression, with the level of statistical signifi-

edge about contraception have further limited access.1

cance set at 0.05. Covariates were included in the model on the basis

The WHISPER or SHOUT study evaluated the impact of a mobile

of empirical evidence from previous studies or an a priori theoretical

phone intervention on knowledge and attitudes to contraception (with

basis for this relationship. Exploratory analyses examined the rea-

a focus on LARCs) and on unintended pregnancy rates in a population

sons for starting and ceasing use of implants and IUDs. The propor-

of FSWs.14 Using baseline data from that trial, the aim of the present

tion of women who had experienced adverse effects was calculated,

study was to assess the prevalence and correlates of LARC use, and

and bivariable logistic regression analyses were used to explore the

explore patterns of use among FSWs in Mombasa, Kenya.

association between cessation of implant use and experience of
adverse effects.

2 | MATERIAL AND METHODS

Inverse probability sample weights were derived for each participant to account for variation in the number of FSWs recruited across
sex-work venues. Given the non-independence of observations owing

The present study analyzed data collected in the WHISPER or

to sampling FSWs by venue, cluster sandwich variance estimation was

SHOUT trial 14 on contraceptive use among FSWs in Kenya between

used to produce corrected standard errors in logistic regression and

September 1, 2016, and May 31, 2017. The study was approved by the

univariate descriptive analyses.

Kenyatta National Hospital, University of Nairobi Ethics and Research
Committee, Kenya, and the Monash University Human Research
Ethics Committee, Australia, and was registered with the Australian

3 | RESULTS

New Zealand Clinical Trial Registry (ACTRN12616000852459). All
participants provided written informed consent.

Among 1728 women invited to participate in the study, 1432 (82.8%)

The WHISPER or SHOUT study recruited women aged

expressed an interest in participating; of these, 120 (8.4%) did not

16–34 years who self-reported sex work in the past 6 months, had

attend screening and 430 (30.0%) were deemed ineligible. The main

a negative urine pregnancy test, and were not planning a pregnancy

reasons for ineligibility were age (n=119, 27.7%) and not owning a

for the next 12 months. Peer educators recruited the women from

mobile phone (n=105, 24.4%) (Fig. 1). In total, 882 eligible women were

sex work venues such as bars and hotels by using two-stage cluster-

enrolled from 93 venues. Three women were subsequently excluded

random sampling. First, 102 sex work venues (clusters) were randomly

from the analysis because they did not answer the questions on con-

selected from a sampling frame of mapped venues.15 The probability

traceptive use, resulting in a sample size of 879 women for the analysis.

of a venue being selected was proportionate to the estimated number

The mean age of the participants was 25.4 years, and 494

of FSWs at that venue. Next, peer educators consecutively recruited

(57.1%) women had a boyfriend or husband (non-paying emo-

FSWs from the selected venues, aiming for 10 women from each.

tional partner) (Table 1). A median of four clients in the past week

Additional venues were approached until at least 860 women were

was reported. Three-quarters of participants (n=675, 76.0%) had

recruited (the target sample size).

ever been pregnant, and 458 (51.3%) had ever had an unintended

After providing written informed consent, participants completed

pregnancy, with 96 (10.8%) having had one in the previous year.

a clinical assessment, point-of-care testing for HIV, and a structured

The prevalence of HIV was 12.1% (95% confidence interval [CI],

interviewer-administered questionnaire. Data were collected on elec-

9.7–14.9). One-quarter of women reported currently using a LARC,

tronic tablets using REDCap electronic data capture tools hosted at

including 204 implant users (22.6%) and 13 IUD users (1.6%)

the Burnet Institute (Vanderbilt University, Nashville, TN, USA).16

(Table 2). Half the women reported using condoms consistently

The outcome of interest, LARC use, was defined as self-reported

with all partners in the past month, with 235 (26.3%) doing so

current use of either contraceptive implants or IUDs. Highly effective

alongside another method. Binge drinking was common (n=176,

186
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Total sex work venues in study area (n=757)*
Estimated total FSWs=(n=8516)

Randomly selected venues (clusters) (n=102)

Included clusters (n=93)
Individuals invited (n=1728)
(mean 18.6/cluster)

Clusters excluded (n=13)
Closed/not operating (n=5)
Unable to recruit at cluster (n=2)
Couldn’t be located (n=1)
Duplicated (sampling error) (n=1)

Not interested in taking part (n=296)

Eligible for full screening (n=1155)
Clusters (n=93)
(mean 12.4/cluster)

Ineligible for full screening (n=277)**
Already in RCT or participated in study
development (n=3)
Not aged 16–34 y (n=109)
No sex work in past 6 mo (n=40)
Not living in the study area (n=26)
No mobile phone (n=88)
Unsupported mobile phone provider (n=11)

Didn’t attend screening (n=120)

Attended screening (n=1035)
Clusters (n=93)
(mean 11.1/cluster)

Enrolled (n=882 from 93 clusters)
(mean 9.5/cluster)

Ineligible (153)**
Already in RCT or participated in study
development (n=7)
Not aged 16-34 y (n=10)
No sex work in past 6 mo (n=4)
Not living in the study area (n=1)
No mobile phone (n=17)
Unsupported mobile phone provider (n=8)
No consent provided (n=3)
Pregnant (n=47)
Planning pregnancy in next year (n=4)
Medical condition preventing enrolment (n=1)
Not SMS literate (n=51)

Excluded from analysis (n=3)
No data on contraceptive use (n=3)

Eligible for analysis (n=879 from 93 clusters)

|
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F I G U R E 1 Flow diagram showing recruitment of the study population for the WHISPER or SHOUT trial as per the Consort 2010 statement:
“extension to cluster randomized trials”.36 Asterisk: total hotspots and number of FSWs per hotspot in the study area, as enumerated by Cheuk
et al.15 Double asterisk: one reason for ineligibility is reported per participant; criteria were determined in the order shown. Abbreviation: FSW,
female sex worker.
T A B L E 1 Demographic, reproductive health, sex work, and
alcohol use characteristics of the study participants.
Characteristic

Value
(n=879)a

TABLE 1

25.4

95% CIb

Education (highest level attained)
104 (11.4)

9.4–13.8

Primary or some secondary

463 (53.5)

49.8–57.2

Secondary or some tertiary

312 (35.1)

31.5–38.8

Protestant

391 (44.1)

40.7–47.6

Catholic

310 (36.1)

32.4–40.0

Muslim

171 (18.9)

15.4–23.0

5 (0.9)

0.3–2.3

<1000

146 (16.2)

13.2–19.8

1000–2000

215 (24.1)

21.1–27.3

>2000

515 (59.7)

55.0–64.3

Religion

Other

95% CIb

High-risk drinkingf

176 (19.9)

16.8–23.5

Sex without a condom while drunk
in past week

104 (12.0)

9.8–14.7

Alcohol use

25.0–25.9

None or some primary

Value
(n=879)a

Characteristic

Demographic
Mean age, y

(Continued)

a

Values are given as median (interquartile range) or number (percentage)
unless stated otherwise. Inverse probability-weighted percentages are
shown (weighted percentages are similar, but not identical to those calculated from counts).
b
Standard errors are corrected by cluster sandwich variance estimation.
c
1000 Kenyan shillings is approximately US $10.
d
Includes brothel, casino, strip club, home, and other.
e
Among those with a boyfriend/husband.
f
Five or more alcoholic drinks on one occasion at least monthly.

Weekly income from sex work, shillingsc

Number of living children

19.9%), and 104 (12.0%) women had had sex without a condom
while drunk in the previous week.
The multivariate logistic regression model included 14 variables
(Table 3). There was no evidence of effect modification, so interac-

0

248 (28.8)

25.0–32.9

1

312 (35.8)

31.8–40.0

of LARCs was correlated with gravidity. The odds of LARC use among

≥2

319 (35.4)

31.2–39.9

women who reported one previous pregnancy was more than 10-fold

494 (57.1)

52.9–61.1

higher than that of nulliparous women (adjusted odds ratio [aOR],

531 (60.0)

55.3–64.5

Current boyfriend/husband
Reproductive health
Intimate partner violence in past
12 mo

tion terms were not added. In the multivariate analysis, current use

11.44; 95% CI, 4.25–30.83), and the association increased with number of pregnancies. Only six nulliparous women used LARCs (2.8%).
A high level of family planning knowledge (aOR, 2.52; 95% CI, 1.78–

Pregnancy history

3.56) and positive attitudes to family planning (aOR, 4.58; 95% CI,

Ever pregnant

675 (76.0)

72.2–79.4

Ever had an unintended pregnancy

458 (51.3)

47.5–55.0

In multivariate analysis, LARC users were younger than non-users

96 (10.8)

8.9–13.2

(aOR per year of age, 0.91; 95% CI, 0.86–0.96). Women with at least

Unintended pregnancy in past
12 mo

2.62–8.00) were also associated with LARC use.

secondary education had a lower odds of LARC use (aOR, 0.42; 95%

Sex and sex work practices

CI, 0.22–0.83) as compared with those who had not completed pri-

Main venue for meeting clients

mary education. The odds of LARC use was nearly doubled for women

Bar with lodging

397 (44.2)

38.0–50.5

Bar without lodging

147 (16.9)

13.5–21.0

those with high contraceptive self-efficacy (OR, 1.86; 95% CI, 1.19–

Lodging/guesthouse

140 (15.1)

10.9–20.5

2.88) in bivariate analysis. However, both variables were strongly cor-

86 (11.0)

7.7–15.5

related with positive attitude to LARC and were not independently

109 (12.8)

9.2–17.5

associated with LARC use after adjustment.

Street/beach
Otherd
Clients in past week

4 (3–6)

whose friends used family planning (OR, 1.92; 95% CI, 1.41–2.61) and

Further analyses explored the experiences of women who had

Number of non-paying partners (boyfriends/husbands) in the past
wke

ever used LARCs, including reasons for commencement and cessation, and adverse effects. Three hundred and two (34.2%) women had

0

40 (7.4)

5.1–10.7

ever used implants. The most commonly reported reason for use was

1

399 (81.7)

77.1–85.5

their effectiveness at preventing pregnancy (n=173, 56.6%), followed

≥2

54 (10.9)

8.0–14.7

by perceived fewer adverse effects (n=49, 16.5%) and longer duration

138 (28.6)

24.3–33.4

of action (n=49, 16.4%) relative to other contraceptives. Overall, 266

Disclosure of sex work status to
boyfriend/husbande

(Continues)

(88.8%) women reported adverse effects, most commonly irregular or

188
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T A B L E 2 Contraceptive use characteristics of the sample
population.
Contraceptive use

No. (%)

a

95% CI

Similar to LARCs, adverse effects were common with other contraceptives, affecting 189 (90.0%) of pill users and 397 (87.4%) of
b

Current contraceptive use
Highly effective method
(± condoms)
Other non-barrier method
(± condoms)
Condoms only

482 (54.6)

49.8–59.3

53 (5.8)

4.2–7.9

injection users. Rates of cessation were also high with these methods: 66.0% for oral contraceptives and 57.0% for injections. Adverse
effects and difficulty of use were the main reasons for ceasing these
methods. Few women reported stopping male (n=11, 2%) or female
(n=1, 6%) condoms.
Among the current implant users, implants had been obtained
from government health centers (n=86, 42.1%), government hospi-

336 (38.8)

34.2–43.5

8 (0.9)

0.4–1.9

Condoms (any)d

845 (96.3)

94.1–97.7

Female condoms

14 (1.6)

0.9–2.6

IUD

13 (1.6)

0.9–2.7

204 (22.6)

19.2–26.3

Male condoms were sourced from varied locations including pharma-

68 (8.3)

6.3–10.9

cies (n=217; 27.4%), government health centers (n=101, 13.4%) and

199 (22.3)

19.3–25.7

1 (0.1)

0.01–0.8

Emergency pill

34 (3.7)

2.6–5.1

Natural method (LAM, cycle
beads, withdrawal

23 (2.5)

1.6–3.9

None
Current methods of contraceptionc

Implant
Pill
Injection
Permanent

669 (76.4)

72.3–80.1

With boyfriends/husbandf

157 (32.2)

28.1–36.6

With all partners

441 (50.4)

46.2–54.5

235 (26.3)

22.6–30.5

With clients

Dual method use (consistent
condom use + another highly
effective method)

vate hospitals or clinics (n=23, 10.9%). Only 10 (5%) women reported
obtaining them from sex-worker drop-in centers. A similar pattern was
noted for IUDs. In contrast, injections were largely obtained from private hospitals or clinics (n=71, 36.0%), and contraceptive pills (n=31,
45%) and emergency contraceptives (n=3, 97%) from pharmacies.

sex-worker drop-in centers (n=86; 11.7%).

4 | DISCUSSION
The present study recruited a large representative sample of FSWs

Consistent condom use during all sex acts in past month
e

tals (n=48, 23.7%), mobile outreach services (n=24, 11.9%), and pri-

Abbreviations: IUD, intra-uterine device; LAM, lactational amenorrhea method.
a
Inverse probability-weighted percentage.
b
Standard errors are corrected by cluster sandwich variance estimation.
c
Categories are not mutually exclusive.
d
Those reporting current use of male or female condoms, or stating use of
condoms mostly/always in the past month.
e
Among those who had sex with clients in the past month (n=874).
f
Among those who had sex with a boyfriend or husband in the past
month (n=486).

from 93 sites in Mombasa, Kenya. Encouragingly, implant use was
approximately fourfold higher than, and the 1-year period prevalence
of unintended pregnancy was approximately half of the values estimated in 2007

1

and 2008.7 Although the two earlier studies did not

use random sampling and included a wider age range, the magnitude
of the differences suggests that the present findings are due to real
changes in the FSW population. The present findings also suggest that
implant use is more prevalent among FSWs (22.6%) than among the
general population (11%).20 Nevertheless, this population still faces
considerable risks, owing to multiple paying and non-paying partners,
low use of dual-method contraception, endemic intimate partner violence, and high-risk drinking with associated sexual risk-taking.
Improvements in implant coverage were not matched by the rate
of IUD use (1.6%), which remained negligible and consistent with low
estimates in the general population (3%).20 Fewer public facilities provide IUDs as compared with other contraceptives.20 Access is also lim-

heavy bleeding (n=139, 45.6%), lighter or no bleeding (n=123, 42.0%),

ited by providers’ misconceptions about IUDs 21 and interpretation of

and pelvic pain (n=93, 30.8%). One-third of those who had ever used

medical eligibility criteria, with many providers continuing to assume

implants were no longer doing so (n=98, 34.1%), mostly because of

that higher-risk women are ineligible for IUD insertion.22

adverse effects (n=81, 83.2%). The adverse effects most strongly

In the present study, gravidity was the strongest independent cor-

associated with cessation were heavier bleeding (OR, 3.26; 95% CI,

relate of LARC use, reflecting similar results in non-sex-worker pop-

1.70–6.28), nausea (OR, 3.73; 95% CI, 2.06–6.74), and weight loss

ulations.23 This may be because women decide to use longer-acting

(OR, 3.79; 95% CI, 2.22–6.47).

methods after completing their family or experiencing unintended

Overall, 40 (4.6%) women had ever used IUDs; the main reasons for
commencing use were perceived fewer adverse effects (n=20, 51%) and

pregnancy. However, it may also reflect an enduring assumption that
LARCs are inappropriate for nulliparous women.21

effectiveness at preventing pregnancy (n=16, 38%). Three-quarters of

Unexpectedly, younger age and lower education were inde-

IUD users reported adverse effects (n=30, 76%), predominantly pelvic

pendently associated with LARC use. Younger, less educated women

pain (n=19, 50%), heavier bleeding (n=10, 26%), and irregular bleeding

may experience greater difficulty in returning to a clinic for short-

(n=8, 22%). Twenty-seven (65%) IUD users had ceased use; 17 of them

acting methods, making LARCs more convenient.24 An association

cited adverse effects as the reason.

between use of any contraceptive by FSWs and older age has been

Ampt ET AL.
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TABLE 3

Characteristics of the study population by LARC use, and bivariate and multivariate logistic regression analyses of LARC use.a
Unadjusted analysis

Variable

LARC use (95% CI)b

Mean age, y

26.1 (25.3–26.8)

OR (95% CI)
1.04 (1.00–1.08)

189

Adjusted analysis
P value
<0.05

OR (95% CI)
0.91 (0.86–0.96)

P value
<0.01

Education (highest level)
None or some primary

28.0 (21.0–36.2)

Primary or some secondary

29.5 (24.4–35.2)

Ref.
1.08 (0.69–1.69)

Ref.

Secondary or some tertiary

14.6 (10.8–19.6)

0.44 (0.27–0.73)

0.95 (0.52–1.72)
<0.01

0.42 (0.22–0.83)

<0.05

Weekly sex work income, shillings
<1000

23.2 (16.1–32.1)

1000–2000

27.1 (21.4–33.6)

Ref.
1.23 (0.70–2.17)

Ref.
1.26 (0.65–2.46)

>2000

23.2 (19.3–27.6)

1.00 (0.62–1.63)

1.06 (0.59–1.91)

Total lifetime pregnancies
0

2.75 (1.21–6.11)

Ref.

1

27.9 (22.4–34.2)

13.71 (5.54–33.89)

<0.001

Ref
11.44 (4.25–30.83)

<0.001

≥2

33.0 (28.1–38.3)

17.42 (7.32–41.42)

<0.001

17.21 (6.32–46.81)

<0.001

38.7 (33.1–44.7)

3.29 (2.40–4.51)

<0.001

2.52 (1.78–3.56)

<0.001

3.6 (3.2–3.9)

1.02 (0.71–1.48)

High FP-specific self-efficacy

27.0 (23.2–31.2)

1.86 (1.19–2.88)

<0.01

1.43 (0.86–2.36)

Positive attitude to FP use

34.7 (30.0–39.9)

5.65 (3.43–9.31)

<0.001

4.58 (2.62–8.00)

Current boyfriend/husband

23.0 (19.1–27.5)

0.87 (0.62–1.22)

Intimate partner violence in last year

27.5 (23.7–31.8)

1.61 (1.16–2.23)

<0.01

28.9 (24.6–33.6)

1.92 (1.41–2.61)

<0.001

2.8 (2.4–3.0)

0.88 (0.63–1.23)

1.03 (0.71–1.49)

Sought health services in past 6 mo

24.2 (20.3–28.5)

1.01 (0.72–1.40)

0.83 (0.56–1.22)

Expect to be treated with respect by
health worker

25.1 (21.6–28.9)

2.94 (1.04–8.25)

Knowledge, self-efficacy, and attitudes
High FP knowledge score
Median general self-efficacy score

1.11 (0.72–1.70)
<0.001

Partner influence
0.97 (0.64–1.46)
1.20 (0.82–1.75)

Social influence
Friends use FP (most or all)
Median stigma score

1.25 (0.85–1.83)

Health service experience
<0.05

1.12 (0.30–4.13)

Abbreviations: CI, confidence interval; FP, family planning; OR, odds ratio.
a
Sample size, n=858 women (21 women had missing values for at least one variable). The proportion using LARC did not differ significantly between those
with and without complete data. Values are given as mean (95% CI), median (IQR), or percentage (95% CI).
b
Inverse probability-weighted percentage. Standard errors are corrected by cluster sandwich variance estimation.

noted,1,25 but it may reflect the predominance of condoms and short-

determinants on sexual health risks.2,25,27 Structural determinants may

acting methods in those studies, or the influence of gravidity. Studies

have a greater influence on use of condoms and other user-dependent

examining LARC use in non-sex-worker populations have rarely found

methods than on LARC use.

a clear association with age,

23,24

and have reported mixed results

regarding education.23,26

Adverse effects were experienced by most women for all highly
effective contraceptive methods and seemed to be more common

Knowledge and positive attitude to family planning were cor-

than reported elsewhere.28,29 The rate of LARC discontinuation was

relates of LARC use, consistent with findings in other populations.26

high, but the duration of use was not known, preventing a comparison

Social norms and contraceptive self-efficacy may lie on the same

with other studies. There was a lower rate of cessation of implants as

causal pathway as positive attitude, or may measure the same under-

compared with IUDs, pills, or injections.30 Reduced bleeding caused

lying construct. Education about LARCs has been found to improve

by implants may be beneficial for sex workers, because bleeding can

attitude and uptake.21 In the present sample, these individual factors

interfere with work. Heavier bleeding was associated with implant

had greater influence on LARC use than structural factors such as the

cessation, consistent with other research.30 Heavy bleeding caused

presence of a boyfriend or husband, sex-work-related stigma, and

by copper IUDs might negatively impact on sex work and exacer-

violence. This is surprising given the known influence of structural

bate iron deficiency anemia, which is likely to be high in the present
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population.14,31 Future studies should investigate whether hormonal

were dominated by implant users. The low number of IUD users also

IUDs, with their tendency to suppress bleeding, would have a higher

precluded further examination of their adverse effects, patterns of

uptake than copper IUDs.32 It would be particularly interesting to

use, and removal. The analysis of adverse effects had some limita-

determine whether negative perceptions of the copper IUD are trans-

tions: there were no data on duration of bleeding, which is a predic-

ferred to the hormonal one. Targeting additional resources at raising

tor of cessation,30 and prolonged bleeding may have been instead

IUD uptake might help to overcome these barriers. It is possible, how-

reported as heavy or irregular.

ever, that such efforts might not raise uptake and that the method has

In conclusion, despite the multiple sexual risks and difficul-

low acceptability in this setting. If that is the case, then it may be better

ties accessing services faced by FSWs in Kenya, implant use has

to target programmatic resources to other family planning priorities.

increased and self-reported unintended pregnancy was lower as

Pelvic pain was a frequently reported adverse effect and is also a

compared with previous estimates in this population. LARC use was

symptom of cervicitis and pelvic inflammatory disease. The long-held

strongly associated with gravidity, knowledge, and attitudes toward

misconception that IUDs cause pelvic inflammatory disease

21

may

family planning. FSWs reported very high rates of contraceptive

lead to their unnecessary removal, when in fact it is safe to leave them

adverse effects. This population would benefit from interventions

in situ while concurrent STIs are treated.

4

to improve uptake of LARCs, particularly IUDs, which are currently

Quality education and counseling on the benefits and adverse
effects of LARCs can improve uptake and continuation rates

under-used.

21,23

by managing expectations, countering common myths, and providing reassurance on the safety of bleeding disturbances.32 However,

AU T HO R CO NT R I B U T I O NS

counseling is likely to be insufficient or incomplete in many settings.30

Under the leadership of the Principal Investigator (SL), FHA, PG,

While Kenya has clear guidelines on contraceptive counseling,5 one
study noted that only 60% of women were counseled on adverse
effects when they obtained contraception.11 Further work is required
to determine how guidelines are applied in practice, particularly for
sex workers who are subject to discrimination by health workers.33
Research in South Africa has indicated that, to improve uptake, LARCs

MSCL, MFC, WJ, MT, MS, PAA, and MH contributed to study design.
GM and CG contributed to data acquisition in Kenya under the supervision of PG. FHA and PAA led the analyses. FHA and MSCL drafted
the first manuscript. All authors contributed to data interpretation,
provided critical input into the draft, and approved the final version
of the manuscript.

need to be available from a wider range of trained service providers,
including mobile outreach clinics for harder-to-reach populations such
as FSWs, and counseling should be reoriented to emphasize LARCs as
a “first-line” contraceptive method.

34

Only 20% of private facilities in

Kenya supply LARCs, whereas more than 65% supply other methods
20

― an observation reflected in the present data. Sex worker drop-in-

centers supplied very few contraceptives (other than male condoms).
This highlights a missed opportunity for these acceptable and widely
used centers 33 to improve access to all methods including LARCs.
The study has some important limitations. The data were collected by self-report, increasing the risk of recall bias and social
desirability bias; however, it would not be possible or practicable
to obtain such personal data by other means. Age was an inclusion
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criterion, so the results cannot be extrapolated to all ages. There
are also limitations around the measurement of pregnancy intention, which may affect the reliability of these data. Some participants
may not have intended to get pregnant, but nonetheless desired
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pregnancy for different reasons. FSWs often have mixed pregnancy
intentions depending on their partners, so they must rely on short-
acting methods with all partners except the desired father.35 They
may also prefer not to disclose a true intention owing to the stigma
surrounding sex work and motherhood.
Interpretation of the analysis is also limited by the cross-sectional
design. Correlates such as knowledge may follow rather than precede LARC use. Other variables that might be associated with the
outcome were not included; for example, stigma from health workers may be an important structural determinant.33 Because there
were very few current users of IUDs, the results of the regression
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